Teethgrinder – Lifestyle
Author:
GH Research PLC
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
GH Research Announces Pricing of $117.5 Million Underwritten Offering
April 29, 2026
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
March 25, 2026